Lithospermoside

• CAT Number: R025342
• CAS Number: 63492-69-3
• Molecular Formula: C14H19NO8
• Molecular Weight: 329.30
• Purity: ≥95%
• Synonyms: (2Z)-2-[(4R,5S,6S)-4,5-dihydroxy-6-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohex-2-en-1-ylidene]acetonitrile
• InChI: InChI=1S/C14H19NO8/c15-4-3-6-1-2-7(17)9(18)13(6)23-14-12(21)11(20)10(19)8(5-16)22-14/h1-3,7-14,16-21H,5H2/b6-3-/t7-,8-,9+,10-,11+,12-,13+,14+/m1/s1
• InChIKey: WIIDBJNWXCWLKF-VVAXPEBGSA-N
• SMILES: C1=CC(=CC#N)C(C(C1O)O)OC2C(C(C(C(O2)CO)O)O)O

Lithospermoside(CAT: R025342) is an iridoid glycoside isolated from Lithospermum species and other medicinal plants traditionally used in East Asian herbal medicine. It has been studied for its antioxidant, anti-inflammatory, hepatoprotective, and cardioprotective effects. Research suggests that Lithospermoside helps regulate oxidative stress, suppress pro-inflammatory mediators, and protect liver and heart tissues from injury, making it relevant in studies of chronic inflammation, liver disease, and cardiovascular dysfunction. Its glycosidic structure enhances solubility and bioavailability, supporting pharmacological applications. With its diverse biological activities, Lithospermoside represents a promising natural compound for drug discovery, metabolic disease research, and therapeutic development.